Hubei Jumpcan unit redeems RMB 17m in deposits
Hubei Jumpcan Pharmaceutical Co., Ltd. (SSE:600566) announced that its wholly-owned subsidiary, Jichuan (Shanghai) Medical Technology Co., Ltd., has redeemed a structured deposit product with Bohai Bank, recovering the principal of RMB 17 million. The investment yielded a return of RMB 106,900, in line with expectations. This redemption is part of the company’s strategy to manage idle raised funds, with the total amount of cash management reaching RMB 56 million. The company has been approved to invest in cash management products up to RMB 580 million.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Hubei Jumpcan Pharmaceutical publishes news
Free account required • Unsubscribe anytime